Bharat Biotech’s intranasal vaccine gets nod for Phase 2/3 trials
New Delhi, Aug 13 : India’s first intranasal vaccine, being developed by Bharat Biotech in collaboration with the Department of Biotechnology and its PSU, the Biotechnology Industry Research Assistance Council (BIRAC), on Friday got regulatory approv…